BlackRock’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.9M | Buy |
|
|||||
|
2025
Q1 | $84.2M | Buy |
|
|||||
|
2024
Q4 | $187M | Buy |
|
|||||
|
2024
Q3 | $280M | Buy |
|
|||||
|
2024
Q2 | $261M | Buy |
|
|||||
|
2024
Q1 | $153M | Buy |
|
|||||
|
2023
Q4 | $50.4M | Buy |
|
|||||
|
2023
Q3 | $29.6M | Sell |
|
|||||
|
2023
Q2 | $37.4M | Buy |
|
|||||
|
2023
Q1 | $30.2M | Buy |
|
|||||
|
2022
Q4 | $30.3M | Buy |
|
|||||
|
2022
Q3 | $32.1M | Buy |
|
|||||
|
2022
Q2 | $17M | Buy |
|
|||||
|
2022
Q1 | $22.8M | Sell |
|
|||||
|
2021
Q4 | $28.7M | Buy |
|
|||||
|
2021
Q3 | $32.3M | Buy |
|
|||||
|
2021
Q2 | $41.5M | Buy |
|
|||||
|
2021
Q1 | $19.3M | Buy |
|
|||||
|
2020
Q4 | $21.8M | Buy |
|
|||||
|
2020
Q3 | $6.14M | Buy |
|